Skip to content

Guidance for Industry: Conducting Clinical Trials With Decentralized Elements

Date: September 23, 2024

The Conducting Clinical Trials With Decentralized Elements final guidance has now been released, and provides recommendations for sponsors, investigators, and other interested parties regarding the implementation of decentralized elements in clinical trials.

Read here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/conducting-clinical-trials-decentralized-elements

 


 

Explore More News

Launch of Annual ACDM Awards

The Association for Clinical Data Management are delighted to announce the introduction of . . .

Read More